CFGS

Concourse Financial Group Securities Portfolio holdings

AUM $1.77B
1-Year Est. Return 17.35%
This Quarter Est. Return
1 Year Est. Return
+17.35%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.68B
AUM Growth
+$83.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
11,786
New
Increased
Reduced
Closed

Top Buys

1 +$6.09M
2 +$5.08M
3 +$4.95M
4
DGRO icon
iShares Core Dividend Growth ETF
DGRO
+$4.03M
5
MBB icon
iShares MBS ETF
MBB
+$3.88M

Sector Composition

1 Technology 8.74%
2 Financials 5.08%
3 Healthcare 4.21%
4 Industrials 4%
5 Consumer Discretionary 3.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NAII icon
7051
Natural Alternatives International
NAII
$25.6M
0
NAIL icon
7052
Direxion Daily Homebuilders & Supplies Bull 3X Shares
NAIL
$617M
0
NAK
7053
Northern Dynasty Minerals
NAK
$1.18B
0
NAMS icon
7054
NewAmsterdam Pharma
NAMS
$3.78B
0
NAMSW icon
7055
NewAmsterdam Pharma Warrant
NAMSW
0
NAN icon
7056
Nuveen New York Quality Municipal Income Fund
NAN
$351M
0
NANC icon
7057
Unusual Whales Subversive Democratic Trading ETF
NANC
$267M
0
FEED
7058
ENvue Medical Inc
FEED
$1.2M
0
NANR icon
7059
SPDR S&P North American Natural Resources ETF
NANR
$876M
0
NAPR icon
7060
Innovator Growth-100 Power Buffer ETF April
NAPR
$199M
0
NAT icon
7061
Nordic American Tanker
NAT
$860M
0
NATH icon
7062
Nathan's Famous
NATH
$413M
0
NATL icon
7063
NCR Atleos
NATL
$2.78B
0
MBOX icon
7064
Freedom Day Dividend ETF
MBOX
$128M
0
MBRX icon
7065
Moleculin Biotech
MBRX
$14.4M
0
MBSD icon
7066
FlexShares Disciplined Duration MBS Index Fund
MBSD
$91.6M
0
MCB icon
7067
Metropolitan Bank Holding Corp
MCB
$906M
0
MCFT icon
7068
MasterCraft Boat Holdings
MCFT
$352M
0
MCH icon
7069
Matthews China Active ETF
MCH
$23.5M
0
MCBS icon
7070
MetroCity Bankshares
MCBS
$787M
0
MCHS icon
7071
Matthews China Discovery Active ETF
MCHS
$3.58M
0
MCHX icon
7072
Marchex
MCHX
$76M
0
MCN
7073
Madison Covered Call & Equity Strategy Fund
MCN
$128M
0
MCR
7074
MFS Charter Income Trust
MCR
$262M
0
MCRB icon
7075
Seres Therapeutics
MCRB
$136M
0